What is PotBotics?
PotBotics operates at the intersection of data technology and the global medical cannabis industry. The company leverages a sophisticated artificial intelligence platform to aggregate and correlate HIPAA-compliant medical data, aiming to empower physicians and patients in personalizing cannabis treatments for improved therapeutic results. A key component of their strategy includes the development of RYAH, a dose-measuring vaporizer designed to yield unique insights into user consumption patterns, cannabinoid research, and broader market trends. PotBotics' robust intellectual property portfolio supports its innovative products and services, positioning it as a data-driven leader in the cannabis ecosystem.
How much funding has PotBotics raised?
PotBotics has raised a total of $2.4M across 1 funding round:
Debt
$2.4M
Debt (2014): $2.4M, investors not publicly disclosed
What's next for PotBotics?
With substantial enterprise-level backing, PotBotics is poised for significant expansion and product development. The recent strategic investment will likely fuel the advancement of its AI data aggregation platform and the commercial rollout of the RYAH vaporizer. Future efforts will probably focus on broadening data acquisition, enhancing predictive treatment analytics, and solidifying its market position as a key technology provider in the regulated cannabis space. Continued innovation and strategic partnerships will be crucial for navigating the evolving landscape of medical cannabis.
See full PotBotics company page
